Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Imatinib mesilat"'
Autor:
Demet Çekdemir, Mehmet Gunduz
Publikováno v:
Sakarya Tıp Dergisi, Vol 10, Iss 1, Pp 107-112 (2020)
Objective: To evaluate retrospectively the efficacy of treatment in chronic myeloid leukemia (CML) patients followed up in our center and receiving imatinib treatment.Materials and Methods: Eighty-five chronic phase CML patients with adequate clinica
Externí odkaz:
https://doaj.org/article/a6c97ad48adb4b09823d0e3f078de1d2
Autor:
Gubič, Špela
Voltage-gated potassium channels are proteins found in cell membranes. They include channels KV1.3 and KV10.1 (hEAG1), which are significantly involved in cancer development. High expression of KV10.1 (hEAG1) has been found in more than 70% of human
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3505::17c264ce380fa8924263b85859220815
https://repozitorij.uni-lj.si/IzpisGradiva.php?id=143394
https://repozitorij.uni-lj.si/IzpisGradiva.php?id=143394
Autor:
Šafarič Tepeš, Polona
Mezenhimski hondrosarkom (MCS) je agresiven podtip hondrosarkoma, ki prizadene predvsem otroke in mladostnike. Pred odkritjem genske fuzije HEY1-NCoA2 v večini MCS, je njegova diagnoza predstavljala izziv zaradi histopatoloških podobnosti s števil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3505::61b8d8bebcfee9ddc0c39bd6e9b3c2b6
https://repozitorij.uni-lj.si/Dokument.php?id=164436&dn=
https://repozitorij.uni-lj.si/Dokument.php?id=164436&dn=
Autor:
I S Nemchenko, N D Khoroshko, A G Turkina, O Yu Vinogradova, M A Sokolova, E M Abakumov, E A Semenova, A V Zakharova, E V Domracheva
Publikováno v:
Терапевтический архив, Vol 79, Iss 7, Pp 87-90 (2004)
Externí odkaz:
https://doaj.org/article/0a63cb214d75460b87062feeacd625f4
Autor:
Uzla, Merve
Kanser tedavilerinde en etkili yöntemlerden biri kemoterapötik tedavidir. Daha çok lösemi tedavisinde kullanılan İmatinib Mesilat, klinik olarak meme kanseri tedavisinde kullanılmasa da bu kanser üzerine etkileri halen daha araştırılmaktad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4866::e83b5fd19a212fc0507dd5fc04549275
https://hdl.handle.net/20.500.12451/9092
https://hdl.handle.net/20.500.12451/9092
Autor:
Kraume, Julian
Tumor location of GIST was gastric in 32, small bowel in 14, rectum in 3 and extraintestinal in 3 patients. Median tumor size was 46 mm. Median mitotic index was 4 per 50 hpf. Resection was achieved R0 in 46 patients, R1 in 4 patients and R2 in 2 pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______707::ecc54f541db773f79711286c89414bfb
https://hdl.handle.net/10900/110345
https://hdl.handle.net/10900/110345
Autor:
Hend Abdelrasoul, Zhengshan Chen, Martin Schrappe, Anila Vadakumchery, Yasar Mehmood Yousafzai, Marc Young, Lennart Lenk, Hassan Jumaa, Vera Schmid, Ahmad Khadour, Christina Halsey, Gunnar Cario, A Alsadeq, Elias Hobeika, Denis M. Schewe, Markus Werner, Markus Müschen, Omar El Ayoubi, Medhanie A. Mulaw, Markus Krämer, Fotini Vogiatzi
Publikováno v:
Nature Communications
Nature Communications, Vol 11, Iss 1, Pp 1-12 (2020)
Nature Communications, Vol 11, Iss 1, Pp 1-12 (2020)
Ph+ acute lymphoblastic leukemia (ALL) is characterized by the expression of an oncogenic fusion kinase termed BCR-ABL1. Here, we show that interleukin 7 receptor (IL7R) interacts with the chemokine receptor CXCR4 to recruit BCR-ABL1 and JAK kinases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3540621ea558f2a55848ca2e7b7d220
https://eprints.gla.ac.uk/217217/13/217217.pdf
https://eprints.gla.ac.uk/217217/13/217217.pdf
Autor:
Salih Aksu, Ali Veysel Kara
Publikováno v:
Dicle Medical Journal, Vol 45, Iss 4, Pp 463-471 (2018)
Volume: 45, Issue: 4 10-13
Dicle Tıp Dergisi
Volume: 45, Issue: 4 10-13
Dicle Tıp Dergisi
Amaç: Kronik myeloid lösemi (KML), immatür hematopoietik kök hücrelerinin neoplastik transformasyonu sonucu oluşan klonal myeloproliferatif bir hastalıktır. Spesifik BCR-ABL protein tirozin kinaz inhibitörü (TKİ) imatinib mesilat klinik uy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00523f9e79cd5a619f012c2d732150de
https://doi.org/10.5798/dicletip.468046
https://doi.org/10.5798/dicletip.468046
Autor:
Mateja Grat, Joško Vučkovič
Publikováno v:
Zdravniški Vestnik, Vol 73, Iss 0 (2004)
Background. Chronic myelogenous leukemia (CML) is a malignant clonal disorder of hematopoietic stem cell. In majority of patients we find reciprocal chromosomal translocation t (9.22) which result in fusion oncoprotein with tyrosine kinase activity.
Externí odkaz:
https://doaj.org/article/e8185070e34d478bb7d28f497b5f8fa5
Autor:
Hekmatshoar, Yalda
Kronik miyeloid lösemi (KML) 9. ve 22. kromozomların resiprokal translokasyonu sonucu oluşan BCR-ABL füzyon geni nedeniyle oluşan bir hematopoetik neoplazidir. KML tedavisinde kullanılan Tirozin Kinaz İnhibitörlerine karşı gelişen direnç,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10208::8f5948eee23fc09ed521bfe0c938a0a0
https://acikbilim.yok.gov.tr/handle/20.500.12812/72672
https://acikbilim.yok.gov.tr/handle/20.500.12812/72672